{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:04:46Z","timestamp":1790759086849,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"General Program Project of Chongqing Shapingba District Science and Technology Bureau","award":["2025180"],"award-info":[{"award-number":["2025180"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Triple-negative breast cancer (TNBC) is exceptionally aggressive, with a high recurrence rate, resistance to chemotherapy, and a tendency to metastasize. The long non-coding RNA growth arrest-specific 5 (GAS5) is associated with TNBC progression; however, the specific mechanism still requires further exploration. Methods: Integrative bioinformatics analyses and qRT-PCR were used to investigate the significant downregulation of GAS5 in TNBC cells and tissues. The functional role and molecular mechanism of GAS5 in inhibiting the progression of TNBC and increasing sensitivity to chemotherapy were investigated using in vitro experiments, including qPCR, Western blot, CCK8 assay, Transwell, Chemotaxis assays, RNA immunoprecipitation, m6A-RNA immunoprecipitation, Chromatin immunoprecipitation, Flow cytometry, ELISA, and Luciferase reporter assays, and in vivo experiments using tumor xenografts. Results: GAS5 was significantly downregulated in TNBC cells and tissues, as well as in chemotherapy-resistant conditions. Functional assays revealed that overexpression of GAS5 attenuated the progression of TNBC and increased their sensitivity to docetaxel (DTX) both in vitro and in vivo. Furthermore, we confirmed that GAS5 recruited YTHDF2 to target MYBL2, which in turn downregulated the chemokine CCL2, which reduced the recruitment of myeloid-derived immunosuppressive cells (MDSCs). In addition, IL-6 from MDSCs downregulated GAS5 to promote TNBC growth and attenuate the sensitivity of TNBC to DTX through the STAT3\/UPF1 axis, forming a feedback loop between tumor cells and MDSCs. Conclusions: These findings illustrated the significance of the GAS5-mediated mutual regulatory pathway between tumor cells and MDSCs in TNBC and provide new avenues for the development of targeted therapies in TNBC.<\/jats:p>","DOI":"10.3390\/cancers18193133","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:00:34Z","timestamp":1790589634000},"page":"3133","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk"],"prefix":"10.3390","volume":"18","author":[{"given":"Junze","family":"Du","sequence":"first","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"},{"name":"Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7917-8996","authenticated-orcid":false,"given":"Xingyun","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Lingfeng","family":"Tang","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Qingqiu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Sisi","family":"Li","sequence":"additional","affiliation":[{"name":"The Biobank of Southwest Hospital, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Gang","family":"Tu","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0119-7658","authenticated-orcid":false,"given":"Shichao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China"},{"name":"Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 401300, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: Pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"Joyce","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"217865","DOI":"10.1016\/j.canlet.2025.217865","article-title":"The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities","volume":"628","author":"Sabit","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1007\/s11010-025-05305-z","article-title":"Ferroptosis in TNBC: Interplay with tumor-infiltrating immune cells and therapeutic implications","volume":"480","author":"Hu","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41388-024-03030-3","article-title":"COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101377","DOI":"10.1016\/j.jcmgh.2024.101377","article-title":"DDR2\/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC","volume":"18","author":"Liu","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kaur, J., Salehen, N., Norazit, A., Rahman, A.A., Murad, N.A.A., Rahman, N.M.A.N.A., and Ibrahim, K. (2022). Tumor Suppressive Effects of GAS5 in Cancer Cells. Noncoding RNA, 8.","DOI":"10.3390\/ncrna8030039"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"155424","DOI":"10.1016\/j.prp.2024.155424","article-title":"GAS5 lncRNA: A biomarker and therapeutic target in breast cancer","volume":"260","author":"Thangavelu","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lambrou, G.I., Hatziagapiou, K., and Zaravinos, A. (2020). The Non-Coding RNA GAS5 and Its Role in Tumor Therapy-Induced Resistance. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207633"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Marcu, A., Nitusca, D., Vaduva, A., Baderca, F., Cireap, N., Coricovac, D., Dehelean, C.A., Seclaman, E., Ilina, R., and Marian, C. (2021). Long Non-Coding RNA Expression in Laser Micro-Dissected Luminal A and Triple Negative Breast Cancer Tissue Samples\u2014A Pilot Study. Medicina, 57.","DOI":"10.3390\/medicina57040371"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wichtowski, M., Ko\u0142aci\u0144ska-Wow, A., Skrzypek, K., Jab\u0142o\u0144ska, E., P\u0142oszka, K., Ko\u0142at, D., Paszek, S., Zawlik, I., P\u0142uciennik, E., and Potocka, N. (2025). Molecular Implications of ADIPOQ, GAS5, GATA4, and YAP1 Methylation in Triple-Negative Breast Cancer Prognosis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110652"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wang, K., Zhu, X., and Yin, Y. (2020). Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00835"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/15384101.2021.1982494","article-title":"Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101004","DOI":"10.1016\/j.gendis.2023.04.035","article-title":"Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration","volume":"11","author":"Qiu","year":"2023","journal-title":"Genes Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12672-024-01051-8","article-title":"GAS5 regulated by FTO-mediated m6A modification suppresses cell proliferation via the IGF2BP2\/QKI axis in breast cancer","volume":"15","author":"Yan","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","article-title":"Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor","volume":"117","author":"Li","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100788","DOI":"10.1016\/j.neo.2022.100788","article-title":"Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis","volume":"28","author":"Deng","year":"2022","journal-title":"Neoplasia"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Nagar, P., Islam, M.R., and Rahman, M.A. (2023). Nonsense-Mediated mRNA Decay as a Mediator of Tumorigenesis. Genes, 14.","DOI":"10.3390\/genes14020357"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-023-01642-3","article-title":"Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6\/STAT3 signaling","volume":"25","author":"Liu","year":"2023","journal-title":"Breast Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"178079","DOI":"10.1016\/j.ejphar.2025.178079","article-title":"Targeting STAT3 pathway: A promising immunotherapeutic strategy for triple-negative breast cancer\u2014Current status and future outlooks","volume":"1005","author":"Malekinejad","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4103\/aja2021117","article-title":"LncRNA GAS5 enhances tumor stem cell-like medicated sensitivity of paclitaxel and inhibits epithelial-to-mesenchymal transition by targeting the miR-18a-5p\/STK4 pathway in prostate cancer","volume":"24","author":"Lu","year":"2022","journal-title":"Asian J. Androl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/jcb.29445","article-title":"lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p\/SUFU signaling","volume":"121","author":"Zheng","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pros.24186","article-title":"Long noncoding RNA GAS5 interacts and suppresses androgen receptor activity in prostate cancer cells","volume":"81","author":"Lv","year":"2021","journal-title":"Prostate"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Basu, S., Nadhan, R., and Dhanasekaran, D.N. (2025). Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications. Cancers, 17.","DOI":"10.3390\/cancers17030472"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12967-025-07370-w","article-title":"Recent progress in immune evasion mechanisms of triple-negative breast cancer","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1172\/JCI99673","article-title":"\u0394Np63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer","volume":"128","author":"Kumar","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dash, S., Firmanty, P., Chomczyk, M., Mohanty, V., Ma, W., and Baran, N. (2026). Targeting MDSCs in cancer: Emerging immunotherapeutic and metabolic strategies. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1749965"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11033-025-11231-6","article-title":"Tumor microenvironment in breast cancer: Cellular crosstalk, pathways, and therapeutic insights","volume":"53","author":"Sharma","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"115318","DOI":"10.1016\/j.addr.2024.115318","article-title":"The role of CCL2\/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine","volume":"209","author":"Pozzi","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/1873-3468.14085","article-title":"Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer","volume":"95","author":"Fiscon","year":"2021","journal-title":"FEBS Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1080\/21655979.2022.2056821","article-title":"Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by MYB proto-oncogene like 2 (MYBL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.it.2025.04.003","article-title":"YTHDF2: A key RNA reader and antitumor target","volume":"46","author":"Xiao","year":"2025","journal-title":"Trends Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2018.11.002","article-title":"Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway","volume":"442","author":"Menu","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., and Cascio, A. (2021). The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020603"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1159\/000479994","article-title":"The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1","volume":"42","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tani, H., Torimura, M., and Akimitsu, N. (2013). The RNA degradation pathway regulates the function of GAS5 a non-coding RNA in mammalian cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055684"},{"key":"ref_40","first-page":"358015","article-title":"Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5","volume":"2013","author":"Williams","year":"2013","journal-title":"Biomed. Res. Int."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:30:14Z","timestamp":1790757014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":40,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193133"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193133","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]}}}